Modipafant (UK-80067) is a potent, orally active, and selective platelet-activating factor (PAF) antagonist; it exhibits approximately twice the intrinsic potency of UK-74505; it effectively antagonizes PAF-induced platelet aggregation in vitro, with its potency significantly increasing upon prolonged preincubation with rabbit platelets (IC50 = 5.6 nM at 2 min vs. IC50 = 0.34 nM at 60 min).